Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Scinai Immunotherapeutics (DE:2F5)
FRANKFURT:2F5
RESEARCH TOOLSreports
Holding DE:2F5?
Track your performance easily
2F5 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€2.50 - €7.30
Previous Close€3.3
Volume0.00
Average Volume (3M)152.00
Market Cap
€2.80M
Enterprise Value€17.13M
Total Cash (Recent Filing)₪4.87M
Total Debt (Recent Filing)₪20.56M
Price to Earnings (P/E)―
Beta0.59
Next Earnings
Nov 26, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding18,855,769
10 Day Avg. Volume0
30 Day Avg. Volume152
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)46.86
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-24.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Scinai Immunotherapeutics News
PremiumCompany Announcements
Scinai Immunotherapeutics to Hold Annual Shareholder Meeting
PremiumCompany Announcements
Scinai Immunotherapeutics Licenses Global RightsPremiumCompany Announcements
Scinai Immunotherapeutics Restructures Debt, Eyes Growth
PremiumCompany Announcements
Scinai Immunotherapeutics Back on Track with Nasdaq
PremiumCompany Announcements
Scinai Immunotherapeutics Restructures Debt, Boosts EquityPremiumCompany Announcements
Scinai Secures $2M Investment Boost
Options Prices
Currently, No data available
---
Ownership Overview
7.40%
Insiders
0.02% Mutual Funds
2.13% Other Institutional Investors
90.45% Public Companies and
Individual Investors
2F5 FAQ
What was Scinai Immunotherapeutics’s price range in the past 12 months?
Scinai Immunotherapeutics lowest stock price was €2.50 and its highest was €7.30 in the past 12 months.
What is Scinai Immunotherapeutics’s market cap?
Currently, no data Available
When is Scinai Immunotherapeutics’s upcoming earnings report date?
Scinai Immunotherapeutics’s upcoming earnings report date is Nov 26, 2024 which is in 38 days.
How were Scinai Immunotherapeutics’s earnings last quarter?
Currently, no data Available
Is Scinai Immunotherapeutics overvalued?
According to Wall Street analysts Scinai Immunotherapeutics’s price is currently Overvalued.
Does Scinai Immunotherapeutics pay dividends?
Scinai Immunotherapeutics does not currently pay dividends.
What is Scinai Immunotherapeutics’s EPS estimate?
Scinai Immunotherapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Scinai Immunotherapeutics have?
Scinai Immunotherapeutics has 838,578 shares outstanding.
What happened to Scinai Immunotherapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Scinai Immunotherapeutics?
Currently, no hedge funds are holding shares in DE:2F5
---
Scinai Immunotherapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-53.50%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-25.36%
Trailing 12-Months
Company Description
Scinai Immunotherapeutics
BiondVax Pharmaceuticals Ltd. is a clinical stage biopharmaceutical company focused on developing and commercializing immunomodulation therapies for infectious diseases. It works on M-001, a synthetic peptide-based protein targeting both seasonal and pandemic strains of the influenza virus. The company was founded by Ron Babecoff and Rami Epstein on July 22, 2003 and is headquartered in Jerusalem, Israel.
---
Technical Analysis
Scinai Immunotherapeutics
―
ADMA Biologics
―
Ibio
―
SELLAS Life Sciences Group
―
Vaxart
―
---